I’ve not heard these three words since my haematology consultation in 2017. But Dr Kalatha, neurologist at Salford Royal Hospital, mentioned them to me. Stem cell therapy. Could my misadventures with prescribed medication, be the key to unlock a new treatment pathway?

in fact, I was called a couple of days ago. The drug I will be trialling is called ‘Frexalimab’. The clinical trial involves 4 weekly infusions (for up to approx. 51months) of the investigational drug and these visits will take place at Salford Royal. Much more to follow!